Ewing sarcoma development and maintenance. We have recently succeeded in gen- We have established an ex vivo mouse model for Ewing sarcoma by introducing EWS-FLI1 cDNA into embryonic osteochondrogenic progenitor cells. 5 The model well recapitulates the morphologies and gene expression profiles of human Ewing sarcoma. In addition, murine Ewing sarcoma is highly dependent on
EWS-FLI1 expression, indicating that EWS-FLI1 drives the expression of genes important for cell survival and proliferation. Thus, it is worthwhile to clarify whether EWS-FLI1 binds DNA and remodels chromatin in mouse sarcoma cells similar to human Ewing sarcoma. Given that the mutation rate is quite low and few recurrent mutations occur in human Ewing sarcoma, [9] [10] [11] EWS-FLI1 and its interaction with the appropriate epigenetic condition are considered to be responsible for the core biological functions of Ewing sarcoma.
Previous studies showed that EWS-FLI1 binds to both canonical Ets binding sites and GGAA microsatellites to regulate downstream target genes. 4, 12, 13 Notably, GGAA microsatellite-associated EWS-FLI1-binding sites are frequently linked to active enhancers and show drastic transactivation by EWS-FLI1, thus emphasizing the significance of these microsatellites. However, the distribution of GGAA microsatellites is not well conserved between human and mouse. 12 Despite this difference, the gene expression profile of Ewing sarcoma in mouse resembles that of human, 5 indicating the importance of clarifying EWS-FLI1 binding in the mouse Ewing sarcoma model.
Moreover, EWS-FLI1-dependent survival and proliferation of mouse
Ewing sarcoma strongly suggests the common important function of
EWS-FLI1 among different organisms. It is therefore important to clarify global EWS-FLI1 binding in mouse Ewing sarcoma and to
evaluate the difference and similarity with that in the human counterpart.
Here, we identified global DNA binding of EWS-FLI1 in mouse
Ewing sarcoma. EWS-FLI1 recognizes GGAA microsatellites, although the frequency is much less than that in human Ewing sarcoma. Moreover, the genes nearest the binding sites in mouse differ considerably from those in humans, suggesting that chromatin remodeling by EWS-FLI1 at the higher order topology might play a crucial role in Ewing sarcoma development and maintenance. We have also identified Foxq1 as a novel cooperative transcription factor that interacts with EWS-FLI1. These results
show novel functional aspects of EWS-FLI1 in Ewing sarcoma development. 
| MATERIALS AND METHODS

| Cell culture and human sarcoma specimens
| Chromatin immunoprecipitation and sequencing
Chromatin immunoprecipitation and sequencing was carried out using the method previously described with modifications. 14 
| Microarray analysis
GeneChip analysis was conducted to determine gene expression profiles. Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Venlo, the Netherlands). The murine Genome HT MG-430 PM Array (Affymetrix, Santa Clara, CA, USA) was hybridized with aRNA probes generated from mouse Ewing sarcoma tissue. After staining with streptavidin-phycoerythrin conjugates, arrays were scanned using an Affymetrix GeneAtlas Scanner and analyzed using GeneSpring GX 12.6 (Agilent Technologies, Santa Clara, CA, USA). 
| Real-time quantitative PCR
| Luciferase assay
Genomic DNA fragments containing both GGAA microsatellites and Fox binding motifs of Trib1 and Nrg1 were cloned into a pGL3 promoter vector (Promega). FLAG-tagged EWS-FLI1 and HA-tagged Foxq1 cDNAs were cloned into pMSV or pcDNA3.1, respectively.
Inserts were generated by PCR with appropriate primers (Table S1 ).
A total of 1 × 10 5 U2OS cells were transfected with the above-mentioned plasmids in indicated combinations. Cells were harvested 48 hours after transfection, and luciferase assays were carried out using the Dual-reporter Luciferase Assay System (Promega) according to manufacturer's procedure. 
| Co-immunoprecipitation assays
| Human microarray analysis
The mRNA expression levels of FOXQ1, FOXF1, FOXB1, TRIB1, and NRG1 in samples from patients with sarcoma were examined by expression profiling by microarray (HG-U133_Plus_2) on the NCBI GEO database (http://www.ncbi.nlm.nih.gov/geo). Ewing sarcoma:
GSE12102, alveolar soft part sarcoma: GSE32569, osteosarcoma:
GSE87437, rhabdomyosarcoma: GSE66533, and synovial sarcoma:
GSE20196 were assessed using GeneSpring GX 12.6.
| Accession number
The ChIP-Seq data sets are accessible through the NCBI GEO database (http://www.ncbi.nlm.nih.gov/geo), with accession number GSE108631, and the microarray data sets with GSE86502 and GSE90978.
| Statistical analysis
Statistical significances were compared with a 2-tailed Student's t test for comparison between 2 groups to determine the P-values and significance shown in the figures and legends.
| RESULTS
| EWS-FLI1 binds enhancer elements in mouse Ewing sarcoma cells
To identify EWS-FLI1-binding sites, we used mouse Ewing sarcoma cell lines ES48 and ES49, which were established from the ex vivo Ewing sarcoma model 5 induced by retroviral introduction of FLAG-tagged human EWS-FLI1 cDNA ( Figure 1A ). ChIP-Seq was carried out using an anti-FLAG antibody. A total of 576 EWS-FLI1-binding peaks were detected in ES49 (Doc. S1). The peaks were distributed in promoter, intergenic, and intragenic regions at frequencies of 0.34%, 20.8%, and 78.8%, respectively ( Figure 1B ). The distribution pattern is comparable to that in human Ewing sarcoma. 4 To show the epigenetic environment around the EWS-FLI1-binding regions, histone modifications including histone H3 lysine 27 acetylation (H3K27Ac) and H3 lysine 27 trimethylation (H3K27me3) were also mapped (Doc. . 
F I G U R E 2 Detection of FOX binding motifs and upregulation of Foxq1 in Ewing sarcoma. A, AME suite motif analysis identification of enrichment of FOX binding motifs within EWS-FLI1-binding peaks. B, Heatmap of expression for 44 murine Fox family genes in mouse Ewing sarcoma (mES) and embryonic superficial zone (eSZ).
5 Six Fox family genes are highlighted in the box with fold changes of expression compared to eSZ. C, Growth suppression of ES49 cells by siRNA-mediated gene silencing (top). Data represent the means ± SEM of 3 independent experiments (*P < .01). Efficiencies of gene silencing were assessed as relative gene expression to Gapdh mRNA by real-time qPCR (bottom). Data represent the means ± SEM of 3 independent experiments (*P < .02, **P < .001). D, Expression of FOXQ1, FOXF1, and FOXB1 in human sarcoma. Gene expression levels were compared on microarray data obtained from the Gene Expression Omnibus (GEO) database. ES, Ewing sarcoma; ASPS, alveolar soft part sarcoma; OS, osteosarcoma; RMS, rhabdomyosarcoma; SS, synovial sarcoma. Numbers of each sarcoma case examined are indicated. E, Expression of FOXQ1, FOXF1, and FOXB1 in human sarcoma cell lines. U937, monocytic leukemia; KAS, clear cell sarcoma; EWS, Ewing sarcoma with EWS-FLI1; KH, Ewing sarcoma with EWS-ERG. Normalized gene expression levels to GAPDH mRNA are indicated as the average of normalized intensity values obtained by real-time qPCR. F, Growth suppression of EWS human Ewing sarcoma cells by FOXQ1 silencing (left). Efficiency of gene silencing was assessed as relative gene expression to Gapdh mRNA by real-time qPCR (center). Data represent the means ± SEM of 3 independent experiments (*P < .02, **P < .001). Efficiency of FOXQ1 silencing was confirmed by western blotting (right)
| EWS-FLI1 and Foxq1 co-regulate the transcriptional machinery
The genes containing EWS-FLI1-binding peaks that include both GGAA microsatellites and FoBS were further investigated. Within these binding regions, 20 out of 26 sites/genes contained FoBS within 100 bp from GGAA microsatellites ( Table 2) . Considering their cancer-associated functions, we focused subsequent investigations on Trib1 and Nrg1. Trib1 was identified as a leukemia disease gene that enhances MAPK phosphorylation and degrades C/EBPα.
22-24
Nrg1 promotes tumor progression in many cancers such as gastric, lung, and breast cancers. [25] [26] [27] Notably, these genes have been previously identified as EWS-FLI1-binding genes in human Ewing sarcoma. 4 EWS-FLI1-binding peaks and an H3K27Ac active enhancer mark could be observed 30 kbp upstream from the TSS of Trib1 and 164 kbp downstream from that of Nrg1 ( Figure 3A ). In particular, the EWS-FLI1-binding peak at the Trib1 locus was located within the super-enhancer site ( Figure 1E ). Enhancer activities of these regions were then examined using luciferase reporter vectors with the sequences that encompass both GGAA microsatellites and FoBS. 
| Foxq1 interacts with EWS-FLI1 through the N-terminus of EWS
Interaction between Foxq1 and EWS-FLI1 was examined using 
| DISCUSSION
In the present study, we identified global DNA binding of EWS- Expression levels were normalized to Gapdh mRNA. Data represent the means ± SEM of 3 independent experiments (*P < .002, **P < .001). D, Effect of FOXQ1 or EWS-FLI1 silencing on TRIB1 and NRG1 in human Ewing sarcoma as detected by real-time qPCR. Expression levels were normalized to GAPDH mRNA. Data represent the means ± SEM of 3 independent experiments (*P < .05, **P < . [40] [41] [42] This signaling axis is also important in multiple cancer types and activation of the signal promotes cancer cell migration or drug resistance. 27, 43, 44 Although the exact functions of TRIB1 and NRG1 in clinical cases of Ewing sarcoma remain to be clarified, the present study highlighted their potential roles as therapeutic targets and/or biomarkers.
There are significant differences in Ewing sarcoma susceptibility among human races. 45 Copy number variation of GGAA microsatellites has been reported and the variation at the EGR2 locus in Ewing sarcoma development was found to be associated with increased gene expression. 46 
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